SCHEMBL807391

SCHEMBL807391

CCC[C@@H]1CCCN(Cc2csc3ccccc23)C1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.60
SMN1; SMN2 Q16637 2/20 0.59
CRHBP P24387 1/20 0.59
CRHR2 Q13324 1/20 0.59
PDE2A O00408 1/20 0.51
DRD2 P14416 7/20 0.47
SLC6A4 P31645 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
DRD4 P21917 6/20 0.47
DRD3 P35462 6/20 0.47
FAAH O00519 1/20 0.42
UTS2R Q9UKP6 1/20 0.41
HTR1A P08908 2/20 0.41
DRD1 P21728 1/20 0.40
HTR2A P28223 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10210997 0.93 CHRNA7 (0.56) CHRNA7SMN1; SMN2CRHBPCRHR2PDE2A
SCHEMBL807400 0.83 CHRNA7 (0.66) CHRNA7SMN1; SMN2CRHBPCRHR2PDE2A
SCHEMBL15084307 0.83 CHRNA7 (0.66) CHRNA7SMN1; SMN2CRHBPCRHR2PDE2A
SCHEMBL807587 0.80 CHRNA7 (0.61) CHRNA7SMN1; SMN2CRHBPCRHR2PDE2A
SCHEMBL15081976 0.80 CHRNA7 (0.61) CHRNA7SMN1; SMN2CRHBPCRHR2PDE2A
SCHEMBL10210828 0.77 CHRNA7 (0.97) CHRNA7SMN1; SMN2CRHBPCRHR2PDE2A
SCHEMBL15084319 0.77 CHRNA7 (0.61) CHRNA7SMN1; SMN2CRHBPCRHR2PDE2A
SCHEMBL15081937 0.77 CHRNA7 (0.57) CHRNA7SMN1; SMN2CRHBPCRHR2PDE2A
SCHEMBL807363 0.76 CHRNA7 (1.00) CHRNA7SMN1; SMN2CRHBPCRHR2DRD2
SCHEMBL13940586 0.76 CHRNA7 (0.76) CHRNA7SMN1; SMN2CRHBPCRHR2PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012036997-A1 FUSED PYRAZOLE DERIVATIVES AS NOVEL ERK INHIBITORS SCHERING CORPORATION (US) 2012-03-22 WO disclosed